Crescent Biopharma, Inc. Common Stock
NASDAQ · CBIO
Fundamentals
Market cap
$537.47M
Price / Earnings ratio
-3.4x
Price / Sales ratio
51.5x
Price / Book ratio
3.4x
Return on assets
-0.9%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


